Silence Share Price
NASDAQ: SLN | Mid Cap | HealthcareSilence Stock Performance
Silence Share Price Today
As of 21 November 2026, Silence Therapeutics Plc's share price is $19.81. The stock opened at $19.82, compared to its previous close of $19.82. During today's trading session, Silence Therapeutics Plc's share price traded between $19.81 and $19.82, with an average price of $19.82. Over the past 52 weeks, the stock has recorded a high of $19.85 and a low of $4.20. In terms of performance, Silence Therapeutics Plc's share price has risen by 186.69% over the last six months and is up 195.67% on a year-on-year basis.
Silence Share Price Chart
About Silence
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
Silence Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $19.75 | $19.81 | +0.28% |
Oct 2026 | $11.00 | $19.75 | +80.16% |
Sep 2026 | $13.37 | $10.96 | -18.42% |
Aug 2026 | $10.43 | $13.44 | +28.37% |
Jul 2026 | $11.05 | $10.47 | -4.73% |
Jun 2026 | $6.76 | $10.99 | +59.04% |
May 2026 | $7.08 | $6.91 | -5.60% |
Apr 2026 | $5.86 | $7.32 | +39.69% |
Mar 2026 | $5.51 | $5.24 | -4.38% |
Feb 2026 | $4.83 | $5.48 | +13.81% |
Jan 2026 | $6.14 | $4.82 | -20.81% |
Dec 2025 | $6.68 | $6.08 | -9.25% |